We are international
Donate
publications TEXT SIZE   
meeting highlights    back

Long-Term Follow-Up of a Phase II Trial of Vel/Dex in Frontline Therapy for Myeloma
By Sundar Jagannath, MD
12.17.06
Long-Term Follow-Up of a Phase II Trial of Vel/Dex in Frontline Therapy for Myeloma



 related articles